Enabling the helpers
Enormous amounts of time and money go into developing new pharmaceutical and medical products, and there’s a small window before each new product’s patent expires. Reducing time from inception to market is enormous because it allows the product to capture market share longer.
“Now more than ever as an industry, we must get smaller, faster and more cost-effective in the way we manufacture drugs, vaccines and therapeutics,” said Kevin Seaver, executive general manager, automation and digital at Cytiva. “By automating processes and analyzing data, we can rethink every step of drug manufacturing and realize economies of scale with flexibility, efficiency and confidence.”
Streamlining the deployment of systems, reducing islands of automation, and decreasing the time spent on gathering and cleaning data all can help biomanufacturing players accelerate their time to market.
“Our aim is to help companies go from seven years down to three or four by doing much of the engineering and automation work upfront,” Seaver said.
Integration and automation across the value chain
The Cytiva Figurate automation platform includes control and communication capabilities that turn data insights into productive outcomes for both upstream and downstream process efficiency gains.
To develop and put its Figurate platform in place, Cytiva adopted the Rockwell Automation PlantPAx® system and used its own Unicorn software to automate its bioprocess equipment. Data is made available through MES applications and can be integrated to include electronic batch records, scheduling and more.
The platform is designed to dramatically streamline deployment of systems for end customers. There are options for Rockwell Automation systems and others, depending on the end-user’s specific needs. Standardized digital libraries – such as product code that's been tested, documented and validated – also can create more efficient process development all the way through manufacturing and automation.
For example, a customer using our PlantPAx system can operate it as a single standalone system but also operate it together with other systems. Through integration the customer can transfer not only the biopharma material but the data along with it.